MB Grožio terapijos studija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
11,542 |
- |
3,758 |
3,570 |
- |
0.54 |
0.14 |
46.91 |
30.93 |
6,403 |
919 |
6,839 |
7,152 |
2022 |
---|
8,790 |
- |
1,015 |
964 |
- |
0.65 |
0.03 |
39.17 |
10.97 |
7,367 |
215 |
5,174 |
5,916 |
2023 |
---|
9,223 |
- |
525 |
499 |
- |
0.73 |
0.01 |
42.20 |
5.41 |
7,756 |
88 |
1,547 |
6,784 |
Register and
explore Okredo data2023 |
---|
9,223 |
- |
525 |
499 |
- |
0.73 |
0.01 |
42.20 |
5.41 |
7,756 |
88 |
1,547 |
6,784 |
Register and
explore Okredo data2023
Turnover (€)
9,223 €5 % *
Sales per employee (€)
-Profit before tax (€)
525 €-48 % *
Net Profit (€)
499 €-48 % *
Profit per employee (€)
-Working capital requirement
0.73 12.31 % *
Debt-to-equity ratio
0.01 -66.67 % *
Total profitability (%)
42.20 %7.74 % *
Net profitability (%)
5.41 %-50.68 % *
Equity (€)
7,756 €5 % *
Amounts Payable And Liabilities (€)
88 €-59 % *
Non-current Assets (€)
1,547 €-70 % *
CurrentAssets (€)
6,784 €15 % *